Biocodex is a pharmaceutical company that develops and markets drugs for patients with severe orphan diseases, focuses on microbiota care, and produces feminine hygiene products.

BIOCODEX

Biocodex

PhaMe – Pharmaceutical and Medical Services

Autisme & Sommeil

Microbiotaevents

Biocodex is a French pharmaceutical company founded in 1953 to develop and market the world’s first probiotic yeast strain, Saccharomyces boulardii CNCM I-745®. Today, Biocodex focuses its business on three main areas: Microbiota care; Women’s health; Orphan diseases. With more than 1,700 employees, Biocodex generated net revenues of above €500 million in 2023, including 1/3 in France and 2/3 internationally. The group is present in more than 100 countries through wholly owned subsidiaries in 16 countries and a network of distributors worldwide. 

To report quality complaint(s) or adverse event(s) related to Biocodex products please visit https://www.biocoreport.com/en/

🔍 #Quizz - Figure of the month – Chiffre du mois 
À votre avis, combien de sites de production compte BIOCODEX ? 🏭

Congratulations to Dr. Nicolas Cenac, the 2024 Biocodex Microbiota Foundation’s international grant winner! 👏
 
🔍  His research investigates how maternal stress might influence the #gut microbiota of newborns and its potential link to conditions like Irritable Bowel Syndrome (#IBS) and visceral pain later in life.
 
Since 2017, The Biocodex Microbiota Foundation rewards international research projects focused on human gut #microbiota related to health and disease. 
 
Read the full interview to learn more about his fascinating investigative journey 👇 https://lnkd.in/eZD4V4yH

🇲🇽 [#México] 🌱 ¡𝗧𝗼𝗱𝗼𝘀 𝘀𝗼𝗺𝗼𝘀 𝗖𝗦𝗥 𝗲𝗻 𝗕𝗶𝗼𝗰𝗼𝗱𝗲𝘅 𝗠𝗲́𝘅𝗶𝗰𝗼!⁣
⁣
Nos complace compartir nuestro segundo proyecto de Responsabilidad Social Corporativa del año.⁣
⁣
🤝 Fomentamos la colaboración con agricultores y aumentamos la conciencia sobre la importancia de la agricultura campesina y la conservación de Xochimilco.⁣
⁣
♻️ Este voluntariado en las Chinampas incluyó actividades de restauración del suelo. ⁣
Algunos impactos:⁣
- Generación de empleo.⁣
- Captura de carbono.⁣
- Producción de alimentos.⁣
- Hábitat para flora y fauna.⁣
- Incremento del ingreso de los agricultores.⁣

¡Gracias arca tierra!
#CSRBiocodex

🎥 𝗘𝘅𝗽𝗹𝗼𝗿𝗲 𝗕𝗶𝗼𝗰𝗼𝗱𝗲𝘅'𝘀 𝗺𝗶𝘀𝘀𝗶𝗼𝗻 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗼𝘂𝗿 𝗻𝗲𝘄 𝘃𝗶𝗱𝗲𝗼! 
As a global pharmaceutical company, BIOCODEX is committed to improving the health and well-being of people around the world 🌍 We focus our efforts on three key areas: microbiota care, women's health and rare diseases.

Immerse yourself in our mission and discover our actions in images through this video.
📸 Watch the video here 
We'd love to read your thoughts and answer your questions in the comments!

#WeDareToInnovate #WePlayCollectively #WeShapeFairRelations #WeCareForOurEcosystem #WomensHealth #OrphanDiseases

🎉 We are happy to announce that we have now…𝟳𝟬.𝟬𝟬𝟬 𝗳𝗼𝗹𝗹𝗼𝘄𝗲𝗿𝘀!
This motivates us fulfilling our mission to provide innovative #healthcare solutions to patients in more than 100 countries worldwide.

Stay in touch! More news on BIOCODEX group in the coming months...

Thank you for being part of our community! 🌍

#Microbiota #WomensHealth #OrphanDiseases

🔍 #Quizz - Figure of the month – Chiffre du mois 
Devinez combien de nationalités compte le groupe BIOCODEX 🌍

🎥 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿 “𝗛𝗲𝗻𝗿𝗶 𝗕𝗼𝘂𝗹𝗮𝗿𝗱 𝗮𝗻𝗱 𝘁𝗵𝗲 𝗥𝗼𝗼𝘁𝘀 𝗼𝗳 𝗣𝗿𝗼𝗯𝗶𝗼𝘁𝗶𝗰𝘀”! 🌿
Immerse yourself in the fascinating story of agronomist Henri Boulard and his passion for plants and yeast, the living micro-organisms that cause fermentation. 
This captivating docu-fiction transports us to early 20th-century Indochina, where Boulard made a revolutionary discovery: the first probiotic yeast strain used in human medicine.

👏 Congratulations to Carla Schad, our USA 🇺🇸 Orphan Diseases Medical Director, who received the 𝗖𝗮𝘁𝗮𝗹𝘆𝘀𝘁 𝗳𝗼𝗿 𝗖𝗵𝗮𝗻𝗴𝗲 𝗔𝘄𝗮𝗿𝗱 from the Dravet Syndrome Foundation at their 2024 Biennial Family & Professional Conference in Minneapolis a few weeks ago, as a token of appreciation for her 8-year commitment to the #Dravet Syndrome community, and more specifically to the siblings of children affected by this disease.
 
💬 “From that very first day, I was hooked, and was inspired to do anything that I could, professionally or personally, for these families and providers. It was my absolute honor to receive the Catalyst for Change Award. With all sincerity, the true honor and privilege is to be part of this community. 
My promise to you…is that I will always keep fighting, and the patient is always first!”
 
We are very proud of Carla, she truly embodies BIOCODEX's values and commitment to #DravetSyndrome patients and their families.
 
#SupportingTheirFuture #DravetButterflyEffect #RareEpilepsies

Nous recrutons (#hiring) pour le poste de Chef de Projet Assurance Qualité - Beauvais - Tous genres (Beauvais, Hauts-de-France). Postulez dès maintenant ou partagez ce post avec votre réseau.

BIOC

COM:BIOCODEX

Biocodex

name

homepage url

country

linkedin url

sector

industry

Description

invested in

Metrics